Saluda Medical Elevates Global Operations Expertise with Barry Regan as New CEO
- bancheta6
- Jul 2
- 1 min read
Minneapolis, MN, June 30, 2025 (PRNewswire) -- Saluda Medical has named Barry Regan as its new President and Chief Executive Officer, effective July 14, 2025, marking a pivotal leadership transition as the company scales commercialization of its Evoke System. Regan brings over 30 years of global operations experience in medical devices and pharmaceuticals, having held senior roles at Dexcom, Wright Medical, Smith & Nephew, and AbbVie. His appointment complements recent additions to Saluda’s executive team, positioning the company to accelerate growth and redefine neuromodulation with its dose-controlled, closed-loop platform. The Board of Directors expressed strong confidence in the leadership team’s ability to transform patient care for chronic neurological conditions.
Read full article here.
Commentaires